The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 19, 1995

Filed:

Aug. 01, 1994
Applicant:
Inventors:

George Baerveldt, Shaker Heights, OH (US);

Larry W Blake, Coto de Caza, CA (US);

Assignee:

Iovision, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M / ;
U.S. Cl.
CPC ...
604-8 ; 604-9 ; 604294 ; 604 50 ; 623-4 ;
Abstract

An implant for use in the treatment of glaucoma is disclosed wherein the implant comprises an elastomeric plate having a non-valved elastomeric drainage tube attached thereto. The plate is curved so as to conform to the spherical anatomy of the eyeball. An annular sloped wall extends from the plate and surrounds the opening of the drainage tube into the plate. The plate is inserted beneath Tenon's capsule and sutured to the sclera utilizing temporary and non-dissolving permanent sutures. The annular wall provides a temporary sealing surface against the sclera. The drainage tube is tunnelled through the sclera and cornea and inserted into the anterior chamber, thus providing fluid communication between the anterior chamber and the elastomeric plate. The annular wall around the tube forms a temporary seal which restricts the drainage of aqueous fluid until formation of the bleb is completed. After bleb formation occurs, the temporary sutures around the wall are removed or dissolve. Once the temporary sutures are gone, the portion of the plate that is not stitched to the sclera floats within the bleb and breaks the seal between the implant and the sclera. Once the seal is broken, unrestricted flow between the anterior chamber and bleb is maintained.

Published as:
US5476445A; WO9603944A1; AU3154495A; EP0773759A1; JPH10503405A; EP0773759B1; ATE186827T1; DE69513530D1; ES2140694T3; DE69513530T2; DK0773759T3; GR3032587T3; PT773759E; JP3240474B2;

Find Patent Forward Citations

Loading…